Assessment of an Endotracheal Tube Securement Device

Hollister

Status

Completed

Conditions

Respiratory Insufficiency

Treatments

Other: Experimental ET Tube Securement Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT01651260

5156-I

Details and patient eligibility

About

Endotracheal intubation is the translaryngeal placement of a tube into the trachea via the nose or mouth. Endotracheal tubes must be securely fixed to prevent movement, which may result in accidental slippage of the tube into a mainstream bronchus or into the pharynx. Hollister Incorporated is assessing the functionality and performance of an endotracheal tube securement device.

Full description

This was a multiple site assessment of the Anchor Fast with enhanced tube protection. Subjects already intubated who required a change of tube-securing device or subjects requiring intubation for greater than 24 hours who meet the inclusion and exclusion criteria were eligible to enroll into the study.The study was open to adult subjects without an existing neck injury who required oral tracheal intubation for greater than 24 hours. Subjects were required to have intact skin on the application site and to be free of facial hair, damaged skin or conditions on the application site (e.g. sunburn, scars, moles or other disfigurations), and significant skin diseases on the application site (e.g. psoriasis, eczema, atopic dermatitis, active cancer) which may have contraindicated participation.

Enrollment

65 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Is 18 years of age or older; male or female and requiring oral tracheal intubation.
Has intact skin on application site.
Willingly signs or their authorized representative willingly signs the Informed Consent.
Is qualified to participate in the opinion of the Investigator.

Exclusion criteria

Has an existing neck injury.
Has protruding upper teeth, without teeth or is unable to wear upper dentures.
Has facial hair.
Has clinically significant skin diseases on the application site which may contraindicate participation, including psoriasis, eczema, atopic dermatitis, active cancer.
Has damaged skin or conditions on the application site which includes sunburn, scars, moles or other disfiguration of the test site.
Has a known or stated allergy to adhesive bandages, or any of the product types being tested.
Uses of topical drugs on the application site.
Uses lotions, creams or oils on the application site.
Currently is participating in any clinical testing which may affect performance of this device.
Has been previously intubated with skin irritation or pressure sores surrounding the mouth.